Intrasense SA reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was EUR 1.91 million compared to EUR 1.81 million a year ago. Net loss was EUR 1.94 million compared to EUR 0.664 million a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.358 EUR | +2.29% | +13.29% | -0.56% |
04-17 | Intrasense: an innovative solution for cancer monitoring | CF |
04-09 | Guerbet: CE certificate for a platform | CF |
1st Jan change | Capi. | |
---|---|---|
-0.56% | 20.13M | |
+7.84% | 218B | |
+7.35% | 184B | |
+13.04% | 135B | |
-1.33% | 62.38B | |
+11.80% | 51.37B | |
+4.81% | 50.9B | |
+0.30% | 40.87B | |
+2.78% | 36.28B | |
+26.14% | 31.88B |
- Stock Market
- Equities
- ALINS Stock
- News Intrasense
- Intrasense SA Reports Earnings Results for the Half Year Ended June 30, 2022